# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-26-037676
Filing Date
2026-03-31
Accepted
2026-03-31 17:27:43
Documents
113
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0283918-10k_mainz.htm iXBRL | 10-K | 1199963
2 | DESCRIPTION OF ORDINARY SHARES | ea028391801ex4-1.htm | EX-4.1 | 45782
3 | LIST OF SUBSIDIARIES | ea028391801ex21-1.htm | EX-21.1 | 1422
4 | CONSENT OF RELIANT CPA | ea028391801ex23-1.htm | EX-23.1 | 2507
5 | CERTIFICATION | ea028391801ex31-1.htm | EX-31.1 | 12078
6 | CERTIFICATION | ea028391801ex31-2.htm | EX-31.2 | 12202
7 | CERTIFICATION | ea028391801ex31-3.htm | EX-31.3 | 12152
8 | CERTIFICATION | ea028391801ex32-1.htm | EX-32.1 | 4142
9 | CERTIFICATION | ea028391801ex32-2.htm | EX-32.2 | 4199
10 | CERTIFICATION | ea028391801ex32-3.htm | EX-32.3 | 4314
11 | GRAPHIC | ea028391801_img1.jpg | GRAPHIC | 52375
12 | GRAPHIC | ea028391801_img2.jpg | GRAPHIC | 10936
13 | GRAPHIC | ea028391801_img3.jpg | GRAPHIC | 21279
| Complete submission text file | 0001213900-26-037676.txt |  | 8670138

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL SCHEMA FILE | mynz-20251231.xsd | EX-101.SCH | 89823
15 | XBRL CALCULATION FILE | mynz-20251231_cal.xml | EX-101.CAL | 56318
16 | XBRL DEFINITION FILE | mynz-20251231_def.xml | EX-101.DEF | 424054
17 | XBRL LABEL FILE | mynz-20251231_lab.xml | EX-101.LAB | 738252
18 | XBRL PRESENTATION FILE | mynz-20251231_pre.xml | EX-101.PRE | 445753
117 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0283918-10k_mainz_htm.xml | XML | 936308

Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41010 | Film No.: 26823680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)